Literature DB >> 22343674

Improved survival in matched unrelated donor transplant for childhood ALL since the introduction of high-resolution matching at HLA class I and II.

J Harvey1, A Green, J Cornish, C Steward, M Cummins, L Keen, S Culliford, A Poles, L Hunt, P Breslin, Y Li, J Moppett.   

Abstract

We present the first detailed study analysing OS in BMT for paediatric ALL following the introduction of high-resolution (HR) HLA matching. A total of 356 consecutive paediatric ALL stem cell transplants performed between 1988 and 2007 were reviewed; 80 of them were performed following the introduction of HR HLA class I and class II matching to the transplant programme in 2002. Comparisons of matched unrelated donor (MUD) transplant outcomes before and after this period were made. Matching at the HR level for HLA-A, -B, -C, -DRB1 and -DQB1 (HR-MUD) correlated with a greater than 25% improvement in 2- and 5-year OS in paediatric ALL patients transplanted with MUDs (P=0.009, P=0.005, respectively). Two-year OS for contemporaneous HLA-matched sibling transplants (80.8%) and HR-MUD transplants (78.8%) was equivalent. At 6%, non-relapse mortality (NRM) in MUD transplants since 2002 was significantly reduced compared with previous epochs. Changes in treatment and epoch-dependent improvements in outcome were reviewed for possible confounders to the influence of HR typing using univariate and multivariate analysis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22343674     DOI: 10.1038/bmt.2012.8

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  8 in total

1.  Correlation between microsatellite discrepancy scores and transplant outcome after haemopoietic SCT for pediatric ALL.

Authors:  J Harvey; A Green; S J Groves; J Cornish; J Moppett; M Cummins; L Keen; S Culliford; A Poles; W Hulme; Y Li; C G Steward
Journal:  Bone Marrow Transplant       Date:  2015-01-12       Impact factor: 5.483

2.  Hematopoietic Stem-Cell Transplantation Does Not Improve the Poor Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group.

Authors:  Jennifer L McNeer; Meenakshi Devidas; Yunfeng Dai; Andrew J Carroll; Nyla A Heerema; Julie M Gastier-Foster; Samir B Kahwash; Michael J Borowitz; Brent L Wood; Eric Larsen; Kelly W Maloney; Leonard Mattano; Naomi J Winick; Kirk R Schultz; Stephen P Hunger; William L Carroll; Mignon L Loh; Elizabeth A Raetz
Journal:  J Clin Oncol       Date:  2019-02-11       Impact factor: 50.717

3.  Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia and the Role of MRD: A Single Centre Experience from India.

Authors:  Divya Subburaj; Lakshman Vaidyanathan; Ramya Uppuluri; Dhaarani Jayaraman; Revathi Raj
Journal:  Indian J Hematol Blood Transfus       Date:  2017-05-20       Impact factor: 0.900

4.  Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research.

Authors:  Michael J Burke; Michael R Verneris; Jennifer Le Rademacher; Wensheng He; Hisham Abdel-Azim; Allistair A Abraham; Jeffery J Auletta; Mouhab Ayas; Valerie I Brown; Mitchell S Cairo; Ka Wah Chan; Miguel A Diaz Perez; Christopher C Dvorak; R Maarten Egeler; Lamis Eldjerou; Haydar Frangoul; Gregory M T Guilcher; Robert J Hayashi; Ahmed Ibrahim; Kimberly A Kasow; Wing H Leung; Richard F Olsson; Michael A Pulsipher; Niketa Shah; Nirali N Shah; Elizabeth Thiel; Julie-An Talano; Carrie L Kitko
Journal:  Biol Blood Marrow Transplant       Date:  2015-08-29       Impact factor: 5.742

5.  The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial.

Authors:  Michael A Pulsipher; Bryan Langholz; Donna A Wall; Kirk R Schultz; Nancy Bunin; William L Carroll; Elizabeth Raetz; Sharon Gardner; Julie M Gastier-Foster; Denise Howrie; Rakesh K Goyal; James G Douglas; Michael Borowitz; Yvonne Barnes; David T Teachey; Candace Taylor; Stephan A Grupp
Journal:  Blood       Date:  2014-02-04       Impact factor: 22.113

6.  Allogeneic hematopoietic cell transplantation in first remission abrogates poor outcomes associated with high-risk pediatric acute myeloid leukemia.

Authors:  Michael J Burke; John E Wagner; Qing Cao; Celalettin Ustun; Michael R Verneris
Journal:  Biol Blood Marrow Transplant       Date:  2013-04-06       Impact factor: 5.742

7.  Resolution of ambiguous HLA genotyping in korean by multi-group-specific sequence-based typing.

Authors:  Yongjung Park; Cha Eun Yoon; Oh-Joong Kwon; Yu-Seun Kim; Hyon-Suk Kim
Journal:  Yonsei Med J       Date:  2014-07       Impact factor: 2.759

8.  Can Graft vs. Leukemia Effect Be Uncoupled From Graft vs. Host Disease? An Examination of Proportions.

Authors:  Elizabeth Krieger; Amir Ahmed Toor
Journal:  Front Immunol       Date:  2020-04-28       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.